APVO - CIK 0001671584
Aptevo Therapeutics Inc. has filed 690 documents with the SEC between 2016 and 2026. The most frequent type is insider trade (221 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Company correspondence | CORRESP | 2023-07-28 | - |
| Company correspondence | CORRESP | 2023-07-28 | - |
| Company correspondence | CORRESP | 2023-07-26 | - |
| Company correspondence | CORRESP | 2023-07-26 | - |
| Company correspondence | CORRESP | 2023-07-21 | - |
| Company correspondence | CORRESP | 2023-07-21 | - |
| Major company event | 8-K | 2023-07-18 | 2023-07-18 |
| Company correspondence | CORRESP | 2023-07-14 | - |
| Company correspondence | CORRESP | 2023-07-14 | - |
| S-1/A | - | 2023-07-14 | - |
| SEC correspondence | UPLOAD | 2023-07-06 | - |
| IPO registration | S-1 | 2023-06-30 | - |
| Insider trade | 4 | 2023-06-02 | 2023-06-01 |
| Insider trade | 4 | 2023-06-02 | 2023-06-01 |
| Insider trade | 4 | 2023-06-02 | 2023-06-01 |
| Insider trade | 4 | 2023-06-02 | 2023-06-01 |
| Insider trade | 4 | 2023-06-02 | 2023-06-01 |
| Insider trade | 4 | 2023-06-02 | 2023-05-31 |
| Major company event | 8-K | 2023-06-02 | 2023-06-02 |
| Quarterly report | 10-Q | 2023-05-11 | 2023-03-31 |
| Major company event | 8-K | 2023-05-11 | 2023-05-11 |
| Proxy materials | DEFA14A | 2023-04-19 | - |
| Annual report to shareholders | ARS | 2023-04-18 | 2022-12-31 |
| Proxy statement | DEF 14A | 2023-04-18 | 2023-06-02 |
| Annual report | 10-K | 2023-03-30 | 2022-12-31 |
| Major company event | 8-K | 2023-03-30 | 2023-03-30 |
| Major company event | 8-K | 2023-03-30 | 2023-03-29 |
| Insider trade | 4 | 2023-03-07 | 2023-03-03 |
| Insider trade | 4 | 2023-03-07 | 2023-03-03 |
| Insider trade | 4 | 2023-03-07 | 2023-03-03 |
| Insider trade (amended) | 4/A | 2023-03-07 | 2016-08-03 |
| Insider trade | 4 | 2023-03-07 | 2023-03-03 |
| New insider ownership | 3 | 2023-03-07 | 2023-03-03 |
| Major company event | 8-K | 2023-03-07 | 2023-03-03 |
| Passive ownership stake (update) | SC 13G/A | 2023-02-14 | - |
| Major company event | 8-K | 2023-02-13 | 2023-02-09 |
| Insider trade | 4 | 2023-01-30 | 2023-01-29 |
| Insider trade | 4 | 2023-01-30 | 2023-01-29 |
| Major company event | 8-K | 2023-01-09 | 2023-01-09 |
| Major company event | 8-K | 2022-12-12 | 2022-12-12 |
| Quarterly report | 10-Q | 2022-11-10 | 2022-09-30 |
| Major company event | 8-K | 2022-11-10 | 2022-11-10 |
| Major company event | 8-K | 2022-11-04 | 2022-11-04 |
| Major company event | 8-K | 2022-09-19 | 2022-09-19 |
| Quarterly report | 10-Q | 2022-08-11 | 2022-06-30 |
| Major company event | 8-K | 2022-08-11 | 2022-08-11 |
| Insider trade | 4 | 2022-08-10 | 2022-08-09 |
| Insider trade | 4 | 2022-08-10 | 2022-08-09 |
| Insider trade | 4 | 2022-08-10 | 2022-08-09 |
| Insider trade | 4 | 2022-08-10 | 2022-08-09 |